Alterations in KP metabolism has been implicated in a range of CNS disorders including depression [193], bipolar disorder [194–196], schizophrenia [197], neurodegenerative disease [197] and sleep disturbances [198]. The gene discussed is NPPA; the disease is depressive symptom measurement.